The home for science and engineering™
English 中文 Русский Português German French Spain Prices and Subscription Policies Begell House Contact Us
Customer Login 0 Shopping Cart
Library Subscription: Guest
Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections
Home Journals Onco Therapeutics Volume 2, 2011 Issue 1
Onco Therapeutics
Editor-in-Chief: Benjamin Bonavida

ISSN Print: 2694-4642

ISSN Online: 2694-4650

Gain Access
More
Articles Current Archive Buy Issue $224.00 Editors Editorial Board Vote BEST Article For Authors Publication Ethics and Malpractice Author Instructions Subscribe Order Journal Access Full Text Recommend to my Librarian Services and Policies Get Permissions Bookmark this Page Register for ToC Alerts and Journal Updates

Volume 2, 2011 Issue 1

DOI: 10.1615/ForumImmunDisTher.v2.i1

FIRST INTERNATIONAL WORKSHOP ON "PROGNOSTIC AND THERAPEUTIC APPLICATIONS OF RKIP IN CANCER"
Held in los angeles, caliFornia, March 19−20, 2010
GUEST EDITORS:
BENJAMIN BONAVIDA, FAHD AL-MULLA, & KAM C. YEUNG
pages iii-vi
DOI: 10.1615/ForumImmunDisTher.v2.i1.10
Phosphatidylenthanolamine Binding Protein aka Raf Kinase Inhibitor Protein: A Brief History of Its Discovery and the Remarkable Diversity of Biological Functions John M. Sedivy
pages 1-12
DOI: 10.1615/ForumImmunDisTher.v2.i1.20
Raf Kinase Inhibitory Protein: A Signal Transduction Modulator and Metastasis Suppressor Eva M. Eves, Marsha Rich Rosner
pages 13-20
DOI: 10.1615/ForumImmunDisTher.v2.i1.30
Dual Role of RKIP in NF-κB Signaling Pathways Sungdae Park, Huihui Tang, Kam C. Yeung
pages 21-34
DOI: 10.1615/ForumImmunDisTher.v2.i1.40
Inhibition of STAT3 Activation by RKIP in Colon Cancer Devasis Chatterjee, Erika L. Moen, Y. Eugene Chin
pages 35-45
DOI: 10.1615/ForumImmunDisTher.v2.i1.50
Locostatin Disrupts Association of Raf Kinase Inhibitor Protein With Binding Proteins by Modifying a Conserved Histidine Residue in the Ligand-Binding Pocket Anwar B. Beshir, Christian E. Argueta, Lochana C. Menikarachchi, Jose A. Gascon, Gabriel Fenteany
pages 47-58
DOI: 10.1615/ForumImmunDisTher.v2.i1.60
Phosphotyrosine Recognition by the Raf Kinase Inhibitor Protein Philip C. Simister, Nicholas M. Burton, R. Leo Brady
pages 59-70
DOI: 10.1615/ForumImmunDisTher.v2.i1.70
RKIP Enhances Angiotensin II - Stimulated Signaling Yasser el Faramawy, Xuebin Fu, Sara H. Agwa, Andreas Langer, Sherif S. Elzahwy, Ursula Quitterer
pages 71-78
DOI: 10.1615/ForumImmunDisTher.v2.i1.80
RKIP-1 and the Cell Cycle: Novel Insight Into Genomic Instability Fahd Al-Mulla
pages 79-87
DOI: 10.1615/ForumImmunDisTher.v2.i1.90
Role of Raf Kinase Inhibitor Protein in Pathophysiology of Prostate Cancer Evan T. Keller
pages 89-94
DOI: 10.1615/ForumImmunDisTher.v2.i1.100
Dual Roles of Raf-1 Kinase Inhibitor Protein in the Regulation of Both Tumor Cell Resistance to Apoptotic Stimuli and Epithelial to Mesenchymal Transition Stavroula Baritaki, Kam C. Yeung, Benjamin Bonavida
pages 95-109
DOI: 10.1615/ForumImmunDisTher.v2.i1.110

Latest Issue

Dissecting the Immune Microenvironment of Malignant Gliomas with Single-Cell Omic Reveals New Treatment Opportunities Bozena Kaminska, Anna M. Lenkiewicz A Brief Review on the Metabolic Evasion Mechanisms of Tumor Cells against T Cells Susana Romero-Garcia, Angeles Carlos-Reyes, Heriberto Prado-Garcia Harnessing Radiation Effects on the Immune System: Balancing Acts Mickael Mathieu, Sadna Budhu, Atif Khan, Adriana Haimovitz-Friedman Resuscitating the Guardian: Current Progress in p53-Based Anti-Tumor Therapy Leader Alfason, Wenfang Li, Farwa Altaf, Shourong Wu, Vivi Kasim Current Trends in Therapeutics for Colon Cancer Seema Kumari, Rakshmitha Marni, Rama Rao Malla Index, Volume 8, 2021
Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections Prices and Subscription Policies Begell House Contact Us Language English 中文 Русский Português German French Spain